A Day Up For Renovaro Biosciences Inc.
Tue, Oct 15, 2024 at 07:37 PM
Renovaro Biosciences Inc. (RENB:NASDAQ) rocketted at $0.71, a gain of 28.4%. On Tue, Oct 15, 2024, RENB:NASDAQ hit a New 2-Week High of $0.71. The stock got featured on our News Catalysts scanner on Thu, Sep 19, 2024 at 10:59 AM in the 'PATNERSHIP' category. From Tue, Oct 01, 2024, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Mon, Jun 10, 2024 at $2.34 with a volume of 10M+.
About Renovaro Biosciences Inc. (RENB:NASDAQ)
Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing, and commercializing gene therapies.
Top 10 Gainers:
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 1445.78%
- Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
- NewGenIvf Group Limited (NIVF:NASDAQ), 159.77%
- Zapata Computing Holdings Inc. (ZPTA:NASDAQ), 59.48%
- JIADE LIMITED (JDZG:NASDAQ), 47.8%
- Digital Brands Group Inc. (DBGI:NASDAQ), 43.93%
- MEDIROM Healthcare Technologies Inc. (MRM:NASDAQ), 35.98%
- Vicarious Surgical Inc. Class A (RBOT:NYSE), 28.73%
- Renovaro Biosciences Inc. (RENB:NASDAQ), 28.4%
- Energy Vault Holdings Inc Com Cl A (NRGV:NYSE), 27.72%